NCT05596669

Brief Summary

Ketamine and magnesium-ketamine are two analgesics that are being studied for use as adjuvants. They were shown to have anaesthetic and analgesic properties, and as a consequence of this finding, it has been postulated that they may have a role in minimising the requirement for analgesic drugs during the postoperative period. The major objective of the research was to examine the pain-relieving effects of ketamine vs ketamine magnesium infusion, as well as their influence on postoperative morphine consumption following nephrectomy; the secondary goal is to assess hemodynamic effects and pain severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
Last Updated

October 27, 2022

Status Verified

October 1, 2022

Enrollment Period

8 months

First QC Date

October 24, 2022

Last Update Submit

October 24, 2022

Conditions

Keywords

KetamineKetamine Magnesium,Analgesic,morphine consumption,Nephrectomy

Outcome Measures

Primary Outcomes (1)

  • Measurement of Post-operative Pain

    Assessment of the pain post-operatively in patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain,The Ramsay sedation scale was utilized to gauge postoperative sedation levels.

    24-hour analgesic after nephrectomy

Study Arms (2)

Effect of Ketamine on Postoperative Morphine Consumption

ACTIVE COMPARATOR

cases in Group I received infusion of 0.15 mg/kg/h for the duration. Following a parenteral bolus dose of magnesium and ketamine (0.3mg/kg),

Drug: Ketamine

Effect of Ketamine Magnesium on Postoperative Morphine Consumption

ACTIVE COMPARATOR

cases in Group II received Ketamine Magnesium group were given a continuous infusion of (0.15mg/kg/h) of ketamine and (10mg/kg/h) of magnesium

Drug: Ketamine

Interventions

to examine the pain-relieving effects of ketamine vs ketamine magnesium infusion, as well as their influence on postoperative morphine consumption following nephrectomy; the secondary goal is to assess hemodynamic effects and pain severity

Also known as: Ketamine Magnesium, Morphine
Effect of Ketamine Magnesium on Postoperative Morphine ConsumptionEffect of Ketamine on Postoperative Morphine Consumption

Eligibility Criteria

Age35 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with elective nephrectomy

You may not qualify if:

  • Pregnant women
  • Cases with severe chronic disease as liver cell failures, CHF
  • cases with allergies to ketamine and magnesium sulphate
  • cases with a history of current regular use of (analgesic, anticonvulsant, antidepressant)
  • chronic pain.
  • mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October 6 University Hospital

Giza, Egypt

Location

MeSH Terms

Interventions

KetamineMorphine

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Nirvana Elshalakany, Professor

    Department of Anesthesia and I.C.U. faculty of Medicine October six university, Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2022

First Posted

October 27, 2022

Study Start

September 1, 2021

Primary Completion

May 1, 2022

Study Completion

May 15, 2022

Last Updated

October 27, 2022

Record last verified: 2022-10

Locations